Sullivan Timothy Eugene Insider Trades

Insider Trading History

Track insider trading activity for Sullivan Timothy Eugene. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$2.93M 71,492 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$30.2M 735,530 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $2.39M 58,140 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.53M 159,080 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $2.93M 71,492 shares
Last Trade
Apr 17, 2026 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$454k 11,096 shares
$40.90
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $5.78M 140,945 shares
Last Trade
Apr 17, 2026 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$454k 11,096 shares
$40.90
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $6.24M 152,041 shares
Last Trade
Jan 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.26M 58,140 shares
$21.63
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $3.85M 93,901 shares
Last Trade
Jan 22, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$224k 10,287 shares
$21.77
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $4.27M 104,188 shares
Last Trade
Jan 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$57.2k 2,892 shares
$19.79
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $4.39M 107,080 shares
Last Trade
Jan 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$85.6k 3,856 shares
$22.19
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $4.96M 120,936 shares
Last Trade
Oct 21, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$283k 10,000 shares
$28.31
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $4.55M 110,936 shares
Last Trade
Oct 21, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$280k 10,000 shares
$28.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $9.56M 232,903 shares
Last Trade
Oct 21, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$283k 10,000 shares
$28.31
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $5.89M 143,665 shares
Last Trade
Sep 08, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$404k 15,000 shares
$26.91
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $9.97M 242,903 shares
Last Trade
Sep 08, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$404k 15,000 shares
$26.91
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $4.55M 110,936 shares
Last Trade
Sep 08, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.19M 42,729 shares
$27.85
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $3.38M 82,500 shares
Last Trade
Jun 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.6M 82,500 shares
$19.39
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $5.28M 128,665 shares
Last Trade
Jan 29, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.1k 546 shares
$29.52
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $5.3M 129,211 shares
Last Trade
Jan 22, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$94k 3,088 shares
$30.43
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $5.43M 132,299 shares
Last Trade
Jan 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.38M 45,929 shares
$30.13
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Financial Officer
Holding Value $3.54M 86,370 shares
Last Trade
Jan 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$51.8k 1,730 shares
$29.96
$41.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up